These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

143 related articles for article (PubMed ID: 2281636)

  • 41. [Serial changes in hemostatic and fibrinolytic states induced by coronary thrombolytic therapy].
    Goto S; Handa S; Abe S; Takahashi E; Kawai Y; Watanabe K; Yoshikawa T; Hori S; Ikeda Y
    J Cardiol; 1993; 23(4):335-41. PubMed ID: 8064582
    [TBL] [Abstract][Full Text] [Related]  

  • 42. [The effect of contrast baths on the hemostatic function of patients with ischemic heart disease].
    Sorokina EI; Ali O
    Vopr Kurortol Fizioter Lech Fiz Kult; 1998; (3):26-8. PubMed ID: 9771141
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Effect of high-dose progestogen on hemostatic properties of blood in patients with endometrial cancer.
    Kaibara M; Watanabe T; Ooka F; Liang SG; Aisaka K; Okinaga S
    Clin Hemorheol Microcirc; 2001; 24(2):93-9. PubMed ID: 11381184
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Eprosartan effect on fibrinolytic/hemostatic variables in arterial hypertension: a comparative study to losartan.
    Makris TK; Stavroulakis G; Papadopoulos DP; Krespi P; Hatzizacharias A; Zilidis A; Tsoukala C; Votteas VE
    Drugs Exp Clin Res; 2004; 30(3):125-32. PubMed ID: 15366789
    [TBL] [Abstract][Full Text] [Related]  

  • 45. [Changes in the system of hemostasis in the pre- and postoperative period].
    Kuzin MI; Dreizina AM; Dobrovol'skiĭ VI; Shumbalina LF; Smolianitskiĭ
    Khirurgiia (Mosk); 1974 Nov; 0(11):64-73. PubMed ID: 4431188
    [No Abstract]   [Full Text] [Related]  

  • 46. Development of a new test for the global fibrinolytic capacity in whole blood.
    Rijken DC; Hoegee-de Nobel E; Jie AF; Atsma DE; Schalij MJ; Nieuwenhuizen W
    J Thromb Haemost; 2008 Jan; 6(1):151-7. PubMed ID: 17973653
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Coagulation, fibrinolysis, and fibrin deposition in acute lung injury.
    Idell S
    Crit Care Med; 2003 Apr; 31(4 Suppl):S213-20. PubMed ID: 12682443
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Changes in coagulation-fibrinolysis balance in blood mononuclear cells and in gastric mucosa from patients with Helicobacter pylori infection.
    Colucci M; Rossiello MR; Pentimone A; Berloco P; Russo F; Di Leo A; Semeraro N
    Thromb Res; 2005; 116(6):471-7. PubMed ID: 16181982
    [TBL] [Abstract][Full Text] [Related]  

  • 49. [Assessment of the thrombocyte-vascular and coagulation components of hemostasis and fibrinolysis in cancer patients].
    Tiutrin II; Udut VV
    Lab Delo; 1986; (7):410-5. PubMed ID: 2429030
    [No Abstract]   [Full Text] [Related]  

  • 50. [State of coagulation hemostasis and fibrinolysis processes in dynamics of rapidly progressing forms of botulinal intoxication].
    Chesnokova NP; Kirichuk VF; Sin'keev MV
    Biull Eksp Biol Med; 1990 Dec; 110(12):637-8. PubMed ID: 2083368
    [TBL] [Abstract][Full Text] [Related]  

  • 51. [A rapid turbidimetric micromethod in the determination of hemostatic and fibrinolytic disorders in arterial hypertension patients of different ages].
    Sushko OO; Lezhen TI; Platonova TM; Chernishenko TM
    Lik Sprava; 1993 Jul; (7):58-60. PubMed ID: 8209534
    [TBL] [Abstract][Full Text] [Related]  

  • 52. [Coagulating and fibrinolytic activity of mixed saliva from patients with hemorrhagic thrombocytovasopathies].
    Filina AI
    Stomatologiia (Mosk); 1985; 64(5):38-9. PubMed ID: 3866364
    [No Abstract]   [Full Text] [Related]  

  • 53. [Hemostatic changes in patients with tumors of the maxillofacial area].
    Egorova LP; Petrishchev NN; Kirsanov AI
    Stomatologiia (Mosk); 1993; 72(4):41-4. PubMed ID: 8108822
    [TBL] [Abstract][Full Text] [Related]  

  • 54. [Functional state of the blood coagulating and fibrinolytic systems in torpid rheumocarditis].
    Moroz VN
    Vrach Delo; 1975 Mar; (3):15-20. PubMed ID: 1121827
    [No Abstract]   [Full Text] [Related]  

  • 55. General changes in hemostasis in gastric cancer.
    Kovacova E; Kinova S; Duris I; Remkova A
    Bratisl Lek Listy; 2009; 110(4):215-21. PubMed ID: 19507648
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Hemostatic modulation with the liver dialysis device in humans with advanced liver disease.
    George MM; Van Thiel DH; Tarasuk G; Chejfec G; McClatchey KD; Hamdani R; Fareed J
    Hepatogastroenterology; 2002; 49(47):1333-9. PubMed ID: 12239938
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Hyperlipidemia and in vivo hemostatic system activation.
    Owen J; Grossman BA; Palmer RH
    Semin Thromb Hemost; 1988 Jul; 14(3):241-5. PubMed ID: 3051388
    [TBL] [Abstract][Full Text] [Related]  

  • 58. [State of the hemostasis system in patients with malignant III-stage neoplasms of the maxilla and larynx].
    Nasyrov VA; Osmonova RO; Rachkov AG
    Vestn Otorinolaringol; 1990; (5):12-5. PubMed ID: 2267685
    [TBL] [Abstract][Full Text] [Related]  

  • 59. [Changes in hemostasis during cancer of the stomach].
    Karpov AB; Udut VV
    Lab Delo; 1990; (7):78. PubMed ID: 1699084
    [No Abstract]   [Full Text] [Related]  

  • 60. [Overview of the relevant aspects of the blood coagulation system--focus and cardiovascular hemostasis].
    Hoffmeister HM
    Kongressbd Dtsch Ges Chir Kongr; 2001; 118():572-5. PubMed ID: 11824317
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.